# US 2014/0235478 A1 · Measurement and Comparison of Immune Diversity by High-Throughput Sequencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0235478 A1
- Document ID: US20140235478A1
- Status: Published application
- Kind: A1
- Application number: 14/172,642
- Filed: 2014-02-04
- Published: 2014-08-21
- Earliest claimed: 2013-02-04
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Stephen R. Quake; Joshua Weinstein; Ning Jiang; Daniel S. Fisher
- Web page: https://patentgrep.com/patent/US20140235478A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/106: Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

High-throughput long read sequencing is used to perform immunogenomic characterization of expressed antibody repertoires in the context of vaccination. Informatic analysis allows global characterizations of isotype distributions, determination of the lineage structure of the repertoire and measure age and antigen related mutational activity. Global analysis of the immune system's clonal structure provides direct insight into the effects of vaccination and provides a detailed molecular portrait of age-related effects.

## Claims

### Claim 1

A method of characterizing an immune response to administration of a vaccine, comprising:
obtaining nucleic acid from a biological sample;
sequencing nucleic acid encoding at least a portion of a subject's immune repertoire; and
comparing sequences obtained to known sequences associated with immune function, thereby to characterize the subject's immune repertoire.

### Claim 2 (depends on 1)

The method of claim 1, wherein the nucleic acid is obtained from a biological sample obtained from an individual at two or more time points.

### Claim 3 (depends on 2)

The method of claim 2, wherein the time points are post-vaccination.

### Claim 4 (depends on 2)

The method of claim 2, wherein the time points are pre- and post-vaccination.

### Claim 5 (depends on 1)

The method of claim 1, wherein two or more vaccines are compared for efficacy.

### Claim 6

A method of selecting a vaccine for a person, comprising:
a) sequencing a population of nucleic acids encoding immunological receptors, or fragments thereof, of said person;
b) using sequence data from step a to characterize said person's immunological response; and
c) selecting a vaccine based on said characterization.

### Claim 7 (depends on 1)

The method of claim 1 wherein the sample is selected from the group consisting of blood, lymph, sputum, and tissue.

### Claim 8 (depends on 1)

The method of claim 1 wherein the nucleic add encodes any of lymphocytes immunoglobulins.

### Claim 9 (depends on 1)

The method of claims 1, further comprising storing sequence information obtained in said sequencing step on a computer-readable medium.

### Claim 10 (depends on 9)

The method of claim 9, further comprising creating a reference database of said sequence information.

### Claim 11 (depends on 1)

The method of claim 1, wherein said comparing step comprises compiling sequence data on a computer-readable medium and processing said data on said computer to identify regions of similarity and difference between said sequences.
